EcoR1 Capital, LLC Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$791.9B
Holdings
36
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XNCRXENCOR ORD | 2,501,557 | $84.4B | 10.66% | |
| 2 | PRTAPROTHENA ORD | 9,426,640 | $73.9B | 9.33% | |
| 3 | FGENEURFIBROGEN ORD | 1,946,307 | $72.0B | 9.09% | Call |
| 4 | —SPARK THERAPEUTICS ORD | 714,789 | $69.3B | 8.75% | |
| 5 | KURAKURA ONCOLOGY ORD | 4,041,953 | $61.3B | 7.74% | |
| 6 | ARGXARGENX ADR REP ORD | 531,165 | $60.5B | 7.64% | |
| 7 | —DICERNA PHARMACEUTICALS ORD | 3,962,978 | $56.9B | 7.19% | |
| 8 | IRWDIRONWOOD PHARMA CL A ORD | 4,671,408 | $40.1B | 5.06% | |
| 9 | MORFMORPHIC HOLDING ORD | 2,161,520 | $39.1B | 4.94% | |
| 10 | SLDBSOLID BIOSCIENCES ORD | 3,342,691 | $34.6B | 4.36% | |
| 11 | —PREVAIL THERAPEUTICS ORD | 2,392,556 | $29.4B | 3.71% | |
| 12 | —HARPOON THERAPEUTICS ORD | 1,463,423 | $20.0B | 2.52% | |
| 13 | BCELATRECA CL A ORD | 1,481,411 | $18.1B | 2.29% | |
| 14 | —CHIASMA ORD | 3,043,827 | $15.1B | 1.90% | |
| 15 | SRPTSAREPTA THERAPEUTICS ORD | 189,745 | $14.3B | 1.80% | |
| 16 | —EXICURE ORD | 5,515,225 | $14.0B | 1.76% | |
| 17 | GOSSGOSSAMER BIO INC ORD | 800,000 | $13.4B | 1.70% | Call |
| 18 | CLDNEUREIGER BIOPHARMACEUTICAL ORD | 1,060,043 | $10.9B | 1.37% | |
| 19 | —CYCLERION THERAPEUTICS ORD | 776,206 | $9.4B | 1.19% | |
| 20 | NXTCNEXTCURE ORD | 250,500 | $7.7B | 0.98% | |
| 21 | RCUSARCUS BIOSCIENCES ORD | 754,505 | $6.9B | 0.87% | |
| 22 | —CURIS ORD | 2,982,208 | $6.7B | 0.84% | |
| 23 | —NEOLEUKIN THERAPEUTICS ORD | 2,265,880 | $6.5B | 0.82% | |
| 24 | ASMBASSEMBLY BIOSCIENCES ORD | 594,900 | $5.8B | 0.74% | Call |
| 25 | MRTXEURMIRATI THERAPEUTICS ORD | 44,221 | $3.4B | 0.44% | |
| 26 | MRUSMERUS ORD | 165,600 | $3.0B | 0.37% | |
| 27 | RAREULTRAGENYX PHARMACEUTICAL ORD | 61,554 | $2.6B | 0.33% | |
| 28 | SURFUSDSURFACE ONCOLOGY ORD | 1,548,888 | $2.2B | 0.28% | |
| 29 | RUBYUSDRUBIUS THERAPEUTICS ORD | 260,152 | $2.0B | 0.26% | |
| 30 | VCELVERICEL ORD | 131,001 | $2.0B | 0.25% | |
| 31 | 1K0IGM BIOSCIENCES ORD | 100,000 | $1.8B | 0.22% | |
| 32 | —ZAFGEN ORD | 1,944,500 | $1.4B | 0.18% | |
| 33 | QNCXCORTEXYME ORD | 49,993 | $1.2B | 0.16% | |
| 34 | AUTLAUTOLUS THERAPEUTICS ADR | 69,155 | $859.0M | 0.11% | |
| 35 | —REGULUS THERAPEUTICS ORD | 1,049,088 | $755.0M | 0.10% | |
| 36 | —UNITY BIOTECHNOLOGY ORD | 51,400 | $314.0M | 0.04% |